Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

April 3, 2020

Primary Completion Date

February 5, 2021

Study Completion Date

April 5, 2021

Conditions
COVID-19
Interventions
OTHER

Blood and derivatives.

Administration of fresh plasma from donor immunized against COVID-19

DRUG

Standard of Care

Standard of care for the treatment of COVID-19 in hospitalized patients

Trial Locations (29)

13005

Hospital General Universitario de Ciudad Real, Ciudad Real

17007

Hospital Doctor Josep Trueta, Girona

20014

Hospital Universitario Donostia, Donostia / San Sebastian

24071

Complejo Asistencial Universitario de León, León

25198

Hospital Universitario Arnau de Vilanova, Lleida

26006

Hospital San Pedro, Logroño

28006

Hospital Universitario La Princesa, Madrid

28009

Hospital General Universitario Gregorio Marañón, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28040

Hospital Clínico San Carlos, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

28050

Hospital Universitario HM Sanchinarro, Madrid

28222

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

31008

Clínica Universidad de Navarra (CUN). Sedes Pamplona y Madrid, Pamplona

Complejo Hospitalario de Navarra, Pamplona

33011

Hospital Universitario de Asturias, Oviedo

35010

Hospital Doctor Negrín, Las Palmas

39008

Hospital Universitario Marqués de Valdecilla, Santander

45007

Complejo Hospitalario de Toledo, Toledo

46014

Hospital General Universitario de Valencia, Valencia

47003

Hospital Clínico Universitario de Valladolid, Valladolid

50009

Hospital Clínico Universitario Lozano Blesa, Zaragoza

Hospital Universitario Miguel Servet, Zaragoza

08221

Hospital Universitario Mútua Terrassa, Terrassa

02006

Hospital General de Albacete, Albacete

08003

Hospital del Mar, Barcelona

08243

Hospital Sant Joan de Deu de Manresa. Fundación Althaia, Manresa

07120

Hospital Universitario Son Espases, Palma de Mallorca

Unknown

Hospital Universitario de Salamanca, Salamanca

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Cristina Avendaño Solá

OTHER

NCT04345523 - Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients | Biotech Hunter | Biotech Hunter